The above results were reported in the Journal of Ethnopharmacol that the 2.5 g·kg−1 SSP effectively treated TNBS-induced colitis, which was the best dose to regulate the expression of IL-10 and IL-4 mRNA [7]. This evidence concerns the gene IL10 and colitis.